LYON, France & NEW YORK--(BUSINESS WIRE)--Regulatory News:
The MEDICREA group (Paris:ALMED) (Alternext Paris: FR0004178572 - ALMED, PEA-PME eligible), which specializes in the development and manufacturing of innovative surgical technologies for the treatment of spinal pathologies, announces its 2015 annual sales.
The MEDICREA group (Paris:ALMED) (Alternext Paris: FR0004178572 - ALMED, PEA-PME eligible), which specializes in the development and manufacturing of innovative surgical technologies for the treatment of spinal pathologies, announces its 2015 annual sales.
